Global Cardiopulmonary Autotransfusion Systems Market to Reach $683.1 Million by 2030
The global market for Cardiopulmonary Autotransfusion Systems estimated at US$574.8 Million in the year 2022, is projected to reach a revised size of US$683.1 Million by 2030, growing at a CAGR of 2.2% over the analysis period 2022-2030. On-Pump Transfusion Device, one of the segments analyzed in the report, is projected to record 2.4% CAGR and reach US$472.2 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Off-Pump Transfusion Device segment is readjusted to a revised 1.8% CAGR for the next 8-year period.
The U.S. Market is Estimated at $171.2 Million, While China is Forecast to Grow at 1.7% CAGR
The Cardiopulmonary Autotransfusion Systems market in the U.S. is estimated at US$171.2 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$118 Million by the year 2030 trailing a CAGR of 1.7% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.2% and 1.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 1.7% CAGR.Select Competitors (Total 12 Featured) -
- Atrium Medical Corporation
- Fresenius SE & Co. KGaA
- Global Blood Resources, LLC
- Haemonetics Corporation
- LivaNova PLC
- Medtronic PLC
- Redax SpA
- Stryker Corporation
- Terumo Medical Corporation -Terumo Interventional Systems
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Cardiopulmonary Autotransfusion Systems - Global Key Competitors Percentage Market Share in 2022 (E)
- Impact of Covid-19 and a Looming Global Recession
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
4. GLOBAL MARKET PERSPECTIVE
- Table 1: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 2: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 3: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
- Table 4: World Cardiopulmonary Autotransfusion Systems Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
- Table 5: World Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 6: World Historic Review for Cardiopulmonary Autotransfusion Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 7: World 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
- Table 8: World Recent Past, Current & Future Analysis for On-Pump Transfusion Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 9: World Historic Review for On-Pump Transfusion Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 10: World 16-Year Perspective for On-Pump Transfusion Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
- Table 11: World Recent Past, Current & Future Analysis for Off-Pump Transfusion Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 12: World Historic Review for Off-Pump Transfusion Device by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 13: World 16-Year Perspective for Off-Pump Transfusion Device by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
- Table 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 15: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 16: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
UNITED STATES
- Cardiopulmonary Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
- Table 17: USA Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 18: USA Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 19: USA 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030
- Table 20: USA Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 21: USA Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 22: USA 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2023 & 2030
CANADA
- Table 23: Canada Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 24: Canada Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 25: Canada 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030
- Table 26: Canada Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 27: Canada Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 28: Canada 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2023 & 2030
JAPAN
- Cardiopulmonary Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
- Table 29: Japan Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 30: Japan Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 31: Japan 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030
- Table 32: Japan Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 33: Japan Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 34: Japan 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2023 & 2030
CHINA
- Cardiopulmonary Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
- Table 35: China Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 36: China Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 37: China 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030
- Table 38: China Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 39: China Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 40: China 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2023 & 2030
EUROPE
- Cardiopulmonary Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
- Table 41: Europe Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 42: Europe Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 43: Europe 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030
- Table 44: Europe Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
- Table 45: Europe Historic Review for Cardiopulmonary Autotransfusion Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 46: Europe 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
- Table 47: Europe Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 48: Europe Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 49: Europe 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2023 & 2030
FRANCE
- Cardiopulmonary Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
- Table 50: France Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 51: France Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 52: France 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030
- Table 53: France Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 54: France Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 55: France 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2023 & 2030
GERMANY
- Cardiopulmonary Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
- Table 56: Germany Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 57: Germany Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 58: Germany 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030
- Table 59: Germany Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 60: Germany Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 61: Germany 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2023 & 2030
ITALY
- Table 62: Italy Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 63: Italy Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 64: Italy 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030
- Table 65: Italy Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 66: Italy Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 67: Italy 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2023 & 2030
UNITED KINGDOM
- Cardiopulmonary Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
- Table 68: UK Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 69: UK Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 70: UK 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030
- Table 71: UK Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 72: UK Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 73: UK 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2023 & 2030
REST OF EUROPE
- Table 74: Rest of Europe Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 75: Rest of Europe Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 76: Rest of Europe 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030
- Table 77: Rest of Europe Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 78: Rest of Europe Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 79: Rest of Europe 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2023 & 2030
ASIA-PACIFIC
- Cardiopulmonary Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
- Table 80: Asia-Pacific Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 81: Asia-Pacific Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 82: Asia-Pacific 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030
- Table 83: Asia-Pacific Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 84: Asia-Pacific Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 85: Asia-Pacific 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2023 & 2030
REST OF WORLD
- Table 86: Rest of World Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 87: Rest of World Historic Review for Cardiopulmonary Autotransfusion Systems by End-Use - Hospitals and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 88: Rest of World 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by End-Use - Percentage Breakdown of Value Sales for Hospitals and Ambulatory Surgery Centers for the Years 2014, 2023 & 2030
- Table 89: Rest of World Recent Past, Current & Future Analysis for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
- Table 90: Rest of World Historic Review for Cardiopulmonary Autotransfusion Systems by Type - On-Pump Transfusion Device and Off-Pump Transfusion Device Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
- Table 91: Rest of World 16-Year Perspective for Cardiopulmonary Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for On-Pump Transfusion Device and Off-Pump Transfusion Device for the Years 2014, 2023 & 2030
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Atrium Medical Corporation
- Fresenius SE & Co. KGaA
- Global Blood Resources, LLC
- Haemonetics Corporation
- LivaNova PLC
- Medtronic PLC
- Redax SpA
- Stryker Corporation
- Terumo Medical Corporation -Terumo Interventional Systems
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 179 |
| Published | April 2024 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 574.8 Million |
| Forecasted Market Value ( USD | $ 683.1 Million |
| Compound Annual Growth Rate | 2.2% |
| Regions Covered | Global |
